Reducing itching, redness, and swelling associated with skin conditions of the scalp. It may also be used for other conditions as determined by your doctor.
Betamethasone Valerate foam is a topical corticosteroid. It works by depressing the formation, release, and activity of different cells and chemicals that cause swelling, redness, and itching.
Betamethasone Valerate indications
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
Betamethasone Valerate Foam, 0.12% is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.
How should I use Betamethasone Valerate?
Use Betamethasone Valerate foam as directed by your doctor. Check the label on the medicine for exact dosing instructions.
An extra patient leaflet is available with Betamethasone Valerate foam. Talk to your pharmacist if you have questions about this information.
Before using for the first time, break the tiny plastic piece at the base of the can's rim by gently pushing back (away from the piece) on the nozzle.
Turn the can upside down and dispense a small amount of Betamethasone Valerate foam onto a clean saucer or other cool, clean surface. Do not dispense directly onto your hands because the foam will begin to melt immediately upon contact with warm skin.
Pick up small amounts of foam with fingers and gently massage into the affected area until foam disappears. Repeat until entire affected area has been treated. Use only enough to cover the entire affected area.
When applying, move the hair away so that the foam can be applied directly to the affected skin.
Wash your hands immediately after using Betamethasone Valerate foam.
Throw away any unused medicine that has been dispensed from the container.
Do not wash or rinse the treated areas immediately after applying Betamethasone Valerate foam.
Do not cover the treating area with bandages, wrappings, or other dressings unless advised to do so by your health care provider.
If you miss a dose of Betamethasone Valerate foam, apply it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.
Ask your health care provider any questions you may have about how to use Betamethasone Valerate foam.
Uses of Betamethasone Valerate in details
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Betamethasone Valerate reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium-strength corticosteroid.
How to use Betamethasone Valerate topical
Use this medication on the skin only. However, do not use it on the face, groin, or underarms unless directed to do so by your doctor.
Wash and dry your hands before using. Clean and dry the affected area. Apply a thin film of medication to the affected area and gently rub in, usually 1-3 times daily or as directed by your doctor. Do not bandage, cover, or wrap the area unless directed to do so by your doctor. If used in the diaper area on an infant, do not use tight-fitting diapers or plastic pants.
After applying the medication, wash your hands unless you are using this medication to treat the hands. When applying this medication near the eyes, avoid getting it in the eyes because this may worsen or cause glaucoma. Also, avoid getting this medication in the nose or mouth. If you get the medication in these areas, rinse with plenty of water.
Use this medication only for the condition for which it was prescribed. Do not use it for longer than prescribed.
Inform your doctor if your condition persists or worsens after 2 weeks.
Betamethasone Valerate description
Betamethasone Valerate Cream: Betamethasone Valerate contains Betamethasone Valerate 0.1% as 17-valerate in a water-miscible base.
It also contains the following excipients: Chlorocresol, macrogol cetostearyl ether, cetostearyl alcohol, white soft paraffin, liquid paraffin, sodium acid phosphate, phosphoric acid, sodium hydroxide and purified water.
Betamethasone Valerate RD Cream: Betamethasone Valerate RD Cream contains Betamethasone Valerate 0.025% as the valerate ester in a water-miscible base.
It also contains the following excipients: Cetostearyl alcohol, macrogol cetostearyl ether, white soft paraffin, liquid paraffin, chlorocresol, anhydrous disodium hydrogen phosphate, citric acid monohydrate and purified water.
Betamethasone Valerate Scalp Application: Betamethasone Valerate Scalp Application contains Betamethasone Valerate 0.1% w/w as valerate. The vehicle contains 50% of isopropyl alcohol, which has antibacterial activity. This preparation complies with the specifications for Betamethasone Valerate Scalp Application BP.
It also contains the following excipients: Carbomer, isopropyl alcohol, sodium hydroxide and purified water.
Betamethasone Valerate dosage
Betamethasone Valerate Cream/Betamethasone Valerate RD Cream:A small quantity should be applied to the affected area 2 or 3 times daily until improvement occurs. It may then be possible to maintain improvement by applying once a day or even less often or by using the appropriate ready-diluted (1 in 4) preparation Betamethasone Valerate RD Cream.
Betamethasone Valerate Cream: Betamethasone Valerate creams are especially appropriate for moist or weeping surfaces.
In the more resistant lesions eg, the thickened plaques of psoriasis on elbows and knees, the effect of Betamethasone Valerate can be enhanced, if necessary, by occluding the treatment area with polythene film. Overnight occlusion only is usually adequate to bring about a satisfactory response in such lesions thereafter, improvement can usually be maintained by regular application without occlusion.
Betamethasone Valerate RD Cream:A small amount of Betamethasone Valerate RD Cream may be applied up to 3 times daily. Betamethasone Valerate RD Cream is especially appropriate for moist or weeping surfaces.
Betamethasone Valerate Scalp Application:A small quantity of Betamethasone Valerate Scalp Application should be applied to the scalp night and morning until improvement is noticeable. It may then be possible to sustain improvement by applying once a day or less frequently.
Due to the flammable nature of Betamethasone Valerate Scalp Application, patients should avoid smoking, heat including the use of hair dryer or being near an open flame during application and immediately after use.
Children: Betamethasone Valerate is contraindicated in children <1 year.
Children are more likely to develop local and systemic side effects of topical corticosteroids and in general, require shorter courses and less potent agents than adults.
Care should be taken when using Betamethasone Valerate to ensure the amount applied is the minimum that provides therapeutic benefit.
Elderly: The greater frequency of decreased hepatic or renal function in the elderly may delay elimination if systemic absorption occurs. Therefore, the minimum quantity should be used for the shortest duration to achieve the desired clinical benefit.
Renal/Hepatic Impairment: In case of systemic absorption (when application is over a large surface area for a prolonged period), metabolism and elimination may be delayed therefore increasing the risk of systemic toxicity. Therefore, the minimum quantity should be used for the shortest duration to achieve the desired clinical benefit.
Concurrent use of barbiturates, carbamazepine, phenytoin, primidone or rifampicin may enhance the metabolism and reduce the effects of systemic corticosteroids. Conversely, oral contraceptives or ritonavir may increase plasma concentrations of corticosteroids.
Use of corticosteroids with potassium-depleting diuretics eg, thiazides or furosemide may cause excessive potassium loss. There is also an increased risk of hypokalemia with concurrent amphotericin B or bronchodilator therapy with xanthines or β2 agonist.
There may be an increased incidence of gastrointestinal bleeding and ulceration when corticosteroids are given with NSAIDs. Corticosteroids may alter response to anticoagulants increasing requirements of antidiabetic drugs and antihypertensives.
Corticosteroids may decrease serum concentrations of salicylates and may decrease the effect of antimuscarinics in myasthenia gravis.
The most frequent adverse event was burning/itching/ stinging at the application site; the incidence and severity of this event were as follows:
Incidence and severity of burning/itching/stinging
Betamethasone Valerate Foam, 0.12%
Other adverse events which were considered to be possibly, probably, or definitely related to Betamethasone Valerate Foam, 0.12% occurred in one patient each; these were paresthesia, pruritus, acne, alopecia, and conjunctivitis.
The following additional local adverse reactions have been reported with topical corticosteroids, and they may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximately decreasing order of occurrence: irritation, dryness, folliculitis, acneiform eruptions hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, and miliaria.
Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria in some patients.
DailyMed. "BETAMETHASONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
The results of a survey conducted on ndrugs.com for Betamethasone Valerate are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Betamethasone Valerate. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported useful
No survey data has been collected yet
Consumer reported price estimates
No survey data has been collected yet
Consumer reported time for results
No survey data has been collected yet
Consumer reported age
No survey data has been collected yet
There are no reviews yet. Be the first to write one!